1. Long‐term follow‐up of patients treated with laser balloon for atrial fibrillation: A high volume center experience with the first‐ and second‐generation laser balloon.
- Author
-
Urbanek, Lukas, Bordignon, Stefano, Tohoku, Shota, Hirokami, Jun, Nagase, Takahiko, Chen, Shaojie, Schaack, David, Chun, K. R. Julian, and Schmidt, Boris
- Subjects
TRANSLUMINAL angioplasty ,POSTOPERATIVE care ,PEARSON correlation (Statistics) ,STATISTICAL hypothesis testing ,PATIENT safety ,LONG-term health care ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,PREOPERATIVE care ,CHI-squared test ,MULTIVARIATE analysis ,SURGICAL complications ,KAPLAN-Meier estimator ,LOG-rank test ,ATRIAL fibrillation ,MEDICAL records ,ACQUISITION of data ,STATISTICS ,LASER angioplasty ,HEALTH facilities ,COMPARATIVE studies ,CATHETER ablation ,DATA analysis software ,PATIENT aftercare ,FLUOROSCOPY ,PROPORTIONAL hazards models - Abstract
Background: Laser balloon (LB) pulmonary vein isolation (PVI) is an established ablation technique for atrial fibrillation (AF). We report long‐term follow‐up and procedural data of LB‐PVI and we compare the first and second LB generation. Methods: Patients undergoing LB ablation with first‐ (LB1) or second‐generation LB (LB2) for AF were retrospectively enrolled and divided into two groups. Procedural endpoint was complete PVI. Clinical success was defined as no recurrence of AF/atrial tachycardia after a 90 days blanking period. Results: 538 patients were included (age 66 ± 10 years, 58% paroxysmal AF), 427 in LB1 and 111 in LB2. 2079 PVs were targeted and 2073 (99.7%) were successfully isolated; 2027 (97.5%) using solely the LB. Additional touch‐up ablation was limited (46 PVs; 2.2%) with no difference between the groups. Procedural (LB1: 120 ± 33 minutes vs. LB2: 99 ± 22 min; p <.001) and fluoroscopy time (LB1: 11.2 ± 5 min vs. LB2: 8.5 ± 3 min; p <.001) were shorter with LB2. The complication rate was 8.9% (LB1: 10.1% vs. LB2: 4.5%; p =.067) with most complications resulting from the access site (21/48). Overall freedom from AF after 1‐year was 73.7% (paroxysmal AF: 76.9%; persistent AF: 69.3%; p <.001) with no difference between the groups (LB1: 73.4% vs. LB2: 74.7%; p =.491). Conclusion: LB showed a high efficacy and acceptable safety, with numerically lower complication rates with the second‐generation LB. Procedure and fluoroscopy times were shorter with LB2. Overall, 73.7% of patients were free from AF at 1‐year, with comparable results among both generations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF